J. H. Lee

发表

Somatic mutations of the trefoil factor family 1 gene in gastric cancer.

H. S. Kim, S. H. Lee, M. Shin, 2000, Gastroenterology.

Mapping of a new target region of allelic loss at 21q22 in primary gastric cancers.

H. S. Kim, S. H. Lee, M. Shin, 2000, Cancer letters.

Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers.

H. S. Kim, S. H. Lee, M. Shin, 1999, Cancer research.

Inactivating mutations of KILLER/DR5 gene in gastric cancers.

H. S. Kim, S. H. Lee, C. H. Park, 2001, Gastroenterology.

Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers.

H. S. Kim, S. H. Lee, M. Shin, 2001, Cancer research.

Genetic analysis of the LKB1/STK11 gene in hepatocellular carcinomas.

H. S. Kim, S. H. Lee, W. Park, 2004, European journal of cancer.

A Clinical Usefulness of Premedication with Hyoscine-N-butyl bromide (Buscopan(R)) in Colonoscopy: A Randomized, Double Blinded, Prospective Study.

J. Y. Park, Lee Mh, Choi Hs, 1997 .

Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma.

H. S. Kim, S. H. Lee, M. Shin, 2001, The Journal of pathology.

BRAF mutations in non-Hodgkin's lymphoma

H. S. Kim, S. H. Kim, S. H. Kim, 2003, British Journal of Cancer.

Induction of proinflammatory mediators requires activation of the TRAF, NIK, IKK and NF‐κB signal transduction pathway in astrocytes infected with Escherichia coli

Y. Oh, J. M. Kim, C. Lee, 2005, Clinical and experimental immunology.